Navigation Links
Study says sharks/rays globally overfished
Date:1/22/2014

cies of rays and sharks, especially those living in relatively shallow water that is accessible to fisheries. The combined effects of overexploitationespecially for the lucrative shark fin soup marketand habit degradation are most severe for the 90 species found in freshwater.

"A whole bunch of wildly charismatic species is at risk. Rays, including the majestic manta and devil rays, are generally worse off than sharks. Unless binding commitments to protect these fish are made now, there is a real risk that our grandchildren won't see sharks and rays in the wild."

Losing these fish will be like losing whole chapters of our evolutionary history says Dulvy. "They are the only living representatives of the first lineage to have jaws, brains, placentas and the modern immune system of vertebrates."

The potential loss of the largest species is frightening for many reasons, says Dulvy. "The biggest species tend to have the greatest predatory role. The loss of top or apex predators cascades throughout marine ecosystems."

The IUCN SSG is calling on governments to safeguard sharks, rays and chimaeras through a variety of measures, including the following: prohibition on catching the most threatened species, science-based fisheries quotas, protection of key habitats and improved enforcement.


'/>"/>

Contact: Carol Thorbes
cthorbes@sfu.ca
778-782-3035
Simon Fraser University
Source:Eurekalert  

Page: 1 2

Related biology news :

1. New CU-Boulder study shows differences in mammal responses to climate change
2. Drug alternatives to antibiotics may not be perfect, study shows
3. Study: Electric drive vehicles have little impact on US pollutant emissions
4. New study reveals links between alcoholic liver disease and the circadian clock
5. A CNIO study finds a molecular scaffolding that maintains skin structure and organisation
6. Wild sparrow study traces social behaviors in the field to specific gene
7. Illinois study identifies 3 risk factors most highly correlated with child obesity
8. Multiple myeloma study uncovers genetic diversity within tumors
9. Nature study discovers chromosome therapy to correct a severe chromosome defect
10. Study shows large carnivore numbers and range declining worldwide
11. Virginia Tech engineer receives NSF grant to study Colorado flood effects on antibiotic resistance
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study says sharks/rays globally overfished
(Date:6/17/2015)... Germany , June 17, 2015 ... QIA) today launched new Investigator ® STR assay kits ... the United States . The new genetic fingerprint ... genomic markers (short tandem repeats or STRs) for DNA matching. ... the quality of DNA in each sample, a novel QIAGEN ...
(Date:6/17/2015)... , June 17, 2015  Crossmatch™, a leading ... that its U.are.U ® 4500 fingerprint readers ... Eateries, Inc., a San Jose, ... to increase security, improve accountability and reduce fraud ... instant, non-repudiable identity confirmation for employee sign in ...
(Date:6/16/2015)... NEW YORK , June 16, 2015  With ... the world, security remains a top concern. The recent ... confirms the need for strong authentication within government ... HYPR Token, a biometric one-time password (OTP) authenticator, has ... Processing Standards (FIPS) 140-2 Level 3 validation for tamper ...
Breaking Biology News(10 mins):QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... The Scripps Research Institute is reporting a discovery that ... everything from the normal processes that govern the everyday ... underlie many diseases, including cancer and septic shock. , ... microRNA and their relationship to the genetic transcripts known ...
... article in Journal of Applied Microbiology investigates how bacteria ... as those of space stations, which feature lowered effects ... modeled reduced gravity" by Paul W. Baker and Laura ... gravity and how for some species, bacteria from the ...
... ability of the brain to recover from such injury as ... that "talk" to one another using the brain chemical acetylcholine, ... Neural repair Group at UCSD have discovered. Their finding in ... by leading to the development of drugs or other treatments ...
Cached Biology News:Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 2Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 3Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression 4Brain-injury rehabilitation depends on acetylcholine circuitry 2
(Date:7/2/2015)... , July 2, 2015 Amici ... Bio-tech procurement company Amici Procurement has chosen Microsoft Cloud ... it move to Office 365.      (Logo: ... small to medium-sized companies in the bio-tech sector with ... of the purchasing cycle to help them obtain best ...
(Date:7/1/2015)... PARK, N.C. and PARIS ... research firm AgBiome, and Genective, key developer of ... accelerate the discovery of new generations of insect ... for insect control to counter the realities of ... with Genective, aligning AgBiome,s unique insect control technology ...
(Date:7/1/2015)... PALO ALTO, Calif. , July 1, 2015 ... company focused on the development of groundbreaking drugs ... sclerosis (ALS), announced today that Robert G. ... Research Center at Sutter Health,s California Pacific Medical ... from The ALS Association for $1.5 million to ...
(Date:7/1/2015)... 1, 2015 InferMed , ... will ... evidence-based clinical s olutions suite   ... information products and services, announced today the acquisition of  InferMed ... (CDS) technology company. InferMed,s Arezzo technology supports clinicians ...
Breaking Biology Technology:Biotech Procurement Company Moves to Office 365 with iomart 2AgBiome and Genective collaborate to create novel insect-resistant crops 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4
... Medivation, Inc. (Nasdaq: MDVN ) ... enrollment in the CONNECTION study, a six-month, confirmatory, pivotal ... patients with mild-to-moderate Alzheimer,s disease. , , ... 598 patients, exceeding the enrollment target of 525 patients. ...
... BioStorage Technologies, Inc., a worldwide provider of ... and cold chain logistics, announced it will participate ... Annual Biorepositories Conference, September 21 to 23, 2009 ... , Biorepositories 2009 is the only U.S.-based ...
... ... everything necessary to build a complete Biotechnology Laboratory, and support US and European power ... Williamstown, ... Stamp™ based Biotechnology laboratory in a box. The CS230000 and CS230001 both are new ...
Cached Biology Technology:Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease 2Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease 3Medivation Completes Enrollment in Confirmatory, Pivotal Phase 3 'CONNECTION' Trial of Dimebon in Patients With Alzheimer's Disease 4BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference 2BioStorage Technologies Takes Lead Sponsorship Role of 2nd Annual IIR Biorepositories Conference 3A-WIT Technologies Releases World's First Low Cost C Stamp(TM) Based Biotechnology Laboratory in a Box 2
Mouse polyclonal antibody raised against a partial recombinant IFNA13. NCBI Entrez Gene ID = 3447...
Mouse polyclonal antibody raised against a partial recombinant NCLN. NCBI Entrez Gene ID = 56926...
...
Mouse monoclonal antibody raised against a partial recombinant WDR5. NCBI Entrez Gene ID = WDR5...
Biology Products: